Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |